Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE

Clinical trial NCT04293458 · COMPLETED

Trial details

NCT number: NCT04293458
Sponsor: Lucid Diagnostics, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Barrett Esophagus Esophageal Adenocarcinoma Barretts Esophagus With Dysplasia Barrett's Esophagus Without Dysplasia

Start date: 2020-02-28
Primary completion: 2022-08-22
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.